|
(PQD3) The role and therapeutic potential of ZNF304 in Ovarian Cancer
|
1R21CA180145-01
|
$208,800
|
$208,800
|
Ozpolat, Bulent
|
UT MD ANDERSON CANCER CTR
|
|
1) Computing Services for DCP; 2) Prostate, Lung, Colorectal, and Ovarian (PLCO)
|
N01CA130008
|
$4,401,871
|
$1,100,468
|
UNKNOWN, UNKNOWN
|
INFORMATION MANAGEMENT SERVICES, INC.
|
|
A Novel Approach for the Routine Screening for Ovarian Cancer
|
5R01CA164940-02
|
$399,736
|
$399,736
|
PANNELL, LEWIS
|
UNIVERSITY OF SOUTH ALABAMA
|
|
A Novel IgE Cancer Therapeutic Specific for the Epithelial Membrane Protein-2
|
1R21CA179680-01
|
$167,475
|
$55,267
|
Daniels-Wells, Tracy
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
|
5R44CA139841-03
|
$619,304
|
$154,826
|
PRABHAKARPANDIAN, BALABHASKAR
|
CFD RESEARCH CORPORATION
|
|
A novel role for PARP1 in regulation of autophagy
|
1R21CA178111-01
|
$165,300
|
$165,300
|
WU, GEN
|
WAYNE STATE UNIVERSITY
|
|
A Pathway-based Approach to Investigate Oncogenic Mechanisms in Ovarian Cancer
|
1K99CA166228-01A1
|
$99,860
|
$99,860
|
Gatza, Michael
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc
|
5R01CA134424-05
|
$366,555
|
$366,555
|
KOSTUK, RAYMOND
|
UNIVERSITY OF ARIZONA
|
|
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer
|
5R01CA168900-02
|
$312,080
|
$156,040
|
Powell, Daniel
|
UNIVERSITY OF PENNSYLVANIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,117,473
|
$55,874
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-37S2
|
$12,499
|
$500
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
$288,674
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$103,603
|
$10,360
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
Adaptations and methodologies for enhanced identification of lead compounds
|
ZIA BC 011468
|
$282,657
|
$141,329
|
Gustafson, Kirk
|
CCR (NCI)
|
|
Addressing Psychosocial Disparities in Rural Hispanic Cancer Survivors
|
5K01CA154938-03
|
$139,976
|
$34,994
|
CEBALLOS, RACHEL
|
FRED HUTCHINSON CAN RES CTR
|
|
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
|
5R01CA138738-05
|
$358,720
|
$179,360
|
Brentjens, Renier
|
SLOAN-KETTERING INST CAN RES
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
1U24CA180921-01
|
$686,990
|
$137,398
|
CROWLEY, REBECCA
|
UNIVERSITY OF PITTSBURGH
|
|
Advancing Clinical Trails in Coastal North Carolina
|
1U10CA176852-01
|
$532,663
|
$37,286
|
MAGUIRE, PATRICK
|
NEW HANOVER REGIONAL MEDICAL CENTER
|
|
An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9)
|
5R21CA170195-02
|
$185,232
|
$185,232
|
Dupuy, Adam
|
UNIVERSITY OF IOWA
|
|
An integrated systems biology approach for ovarian cancer biomarker discovery
|
4U01CA152755-04
|
$248,982
|
$248,982
|
DIAMANDIS, ELEFTHERIOS
|
MT SINAI HOSP-SAMUEL LUNENFELD RES INST
|
|
Analysis of BRCA1 recombination functions
|
5R01CA095175-10
|
$277,509
|
$138,755
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca
|
1R01CA172667-01
|
$346,404
|
$346,404
|
Nomura, Daniel
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Antibody directed delivery of short interfering RNA for the treatment of ovarian
|
5K08CA163603-02
|
$170,631
|
$170,631
|
PALANCA-WESSELS, MARIA
|
FRED HUTCHINSON CAN RES CTR
|
|
Antibody Therapy of Cancer
|
ZIA BC 010891
|
$650,270
|
$65,027
|
Ho, Mitchell
|
CCR (NCI)
|
|
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
|
5R01CA092160-12
|
$284,228
|
$93,795
|
TIGYI, GABOR
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
Applied Molecular Pathology Laboratory
|
ZIC BC 011257
|
$157,514
|
$15,751
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$3,750
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-35
|
$3,676,771
|
$183,839
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
Array Microscope Assay for Cancer Cell Mechanics
|
5R33CA155618-03
|
$307,678
|
$153,839
|
SUPERFINE, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Atlantic Breast and Gynecologic Clinical Validation Center
|
5U01CA084955-14
|
$468,371
|
$117,093
|
Marks, Jeffrey
|
DUKE UNIVERSITY
|
|
B7-H1 Signaling in Ovarian Cancer
|
5R01CA164122-02
|
$291,600
|
$174,960
|
Curiel, Tyler
|
UNIV OF TX HSC, SA
|
|
Bacterial Minicells for Cancer Therapeutics
|
1F32CA165657-01A1
|
$52,190
|
$17,745
|
Danino, Tal
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
$723,259
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$865
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$61,856
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
BCDDF: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182-01030
|
$51,681
|
$10,336
|
Schairer, Catherine
|
DCEG (NCI)
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-12S1
|
$125,000
|
$5,000
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-12
|
$692,608
|
$27,704
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Biobehavioral Influences and the Ovarian Tumor Microenvironment
|
3R01CA140933-05S1
|
$44,314
|
$44,314
|
LUTGENDORF, SUSAN
|
UNIVERSITY OF IOWA
|
|
Biobehavioral Influences and the Ovarian Tumor Microenvironment
|
5R01CA140933-05
|
$447,202
|
$447,202
|
LUTGENDORF, SUSAN
|
UNIVERSITY OF IOWA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$70,825
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biomedical Applications of Expanded Porphyrins
|
5R01CA068682-22
|
$301,027
|
$301,027
|
SESSLER, JONATHAN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
Bmi-1, a potential therapeutic target in ovarian cancer
|
7R01CA157481-02
|
$304,071
|
$304,071
|
Bhattacharya, Resham
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
5R01CA136512-05
|
$480,837
|
$120,209
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INST
|
|
Breast and Other Cancers in the California Teachers Cohort
|
5R01CA077398-15
|
$2,365,386
|
$236,539
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Breast and Ovary Cancer Clinical Validation Center
|
5U01CA152637-04
|
$881,335
|
$440,668
|
Li, Christopher
|
FRED HUTCHINSON CAN RES CTR
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145-07040
|
$454,638
|
$68,196
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women
|
5R01CA129142-05
|
$503,480
|
$251,740
|
KINNEY, ANITA
|
UNIVERSITY OF UTAH
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$845,663
|
$84,566
|
Restifo, Nicholas
|
CCR (NCI)
|
Total relevant funding to Ovarian Cancer for this search: $100,558,561
|